Mutations in <it>PIK3CA </it>are infrequent in neuroblastoma

Mutations in <it>PIK3CA </it>are infrequent in neuroblastoma

<p>Abstract</p> <p>Background</p> <p>Neuroblastoma is a frequently lethal pediatric cancer in which <it>MYCN </it>genomic amplification is highly correlated with aggressive disease. Deregulated <it>MYC </it>genes require co-operative lesions to f...

Full description

Bibliographic Details
Main Authors:	Mazanek Pavel, Morgan Brian T, Dam Vincent, Hogarty Michael D
Format:	Article
Language:	English
Published:	BMC 2006-07-01
Series:	BMC Cancer
Online Access:	http://www.biomedcentral.com/1471-2407/6/177

Similar Items

Mutations of <it>PIK3CA </it>in gastric adenocarcinoma
by: So Samuel, et al.
Published: (2005-03-01)

PIK3CA Mutational Analysis of Parathyroid Adenomas
by: Aaliyah Riccardi, et al.
Published: (2020-06-01)

Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma
by: Bardeesy Nabeel, et al.
Published: (2011-02-01)

Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients
by: Li Chen, et al.
Published: (2018-04-01)

Relationship of KRAS and PIK3CA gene mutation in colorectal cancer
by: Fan-Bao Yao, et al.
Published: (2016-05-01)

Frequency and spectrum of PIK3CA somatic mutations in breast cancer
by: Olga Martínez-Sáez, et al.
Published: (2020-05-01)

PIK3CA genotype and a PIK3CA mutation-related gene signature and response to everolimus and letrozole in estrogen receptor positive breast cancer.
by: Sherene Loi, et al.
Published: (2013-01-01)

Mutation and genomic amplification of the PIK3CA proto-oncogene in pituitary adenomas
by: C.B. Murat, et al.
Published: (2012-09-01)

Mutation and genomic amplification of the PIK3CA proto-oncogene in pituitary adenomas
by: C.B. Murat, et al.
Published: (2012-09-01)

Correction: PIK3CA Genotype and a PIK3CA Mutation-Related Gene Signature and Response to Everolimus and Letrozole in Estrogen Receptor Positive Breast Cancer.
by: Sherene Loi, et al.
Published: (2019-01-01)

Correlation between circulating cell‐free PIK3CA tumor DNA levels and treatment response in patients with PIK3CA‐mutated metastatic breast cancer
by: Annette R. Kodahl, et al.
Published: (2018-06-01)

PIK3CA in colorectal cancer
by: Gieri eCathomas
Published: (2014-03-01)

Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer
by: Yujun Hao, et al.
Published: (2016-06-01)

Prediction of PIK3CA mutations from cancer gene expression data.
by: Jun Kang, et al.
Published: (2020-01-01)

Oncogenic PIK3CA Mutation and Dysregulation in Human Salivary Duct Carcinoma
by: Wanglong Qiu, et al.
Published: (2014-01-01)

PIK3CA Mutation in Colorectal Cancer: Relationship with Genetic and Epigenetic Alterations
by: Katsuhiko Nosho, et al.
Published: (2008-06-01)

PIK3CA gene mutation associated with poor prognosis of lung adenocarcinoma
by: Zhang L, et al.
Published: (2013-05-01)

PIK3CA activating mutation in colorectal carcinoma: associations with molecular features and survival.
by: Christophe Rosty, et al.
Published: (2013-01-01)

PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers.
by: Filip Janku, et al.
Published: (2011-01-01)

Clinical-Pathologic Analysis of Breast Cancer With PIK3CA Mutations in Chinese Women
by: Jing Lian MS, et al.
Published: (2020-10-01)

The utility of TP53 and PIK3CA mutations as prognostic biomarkers in salivary adenoid cystic carcinoma
by: Adderley, H., et al.
Published: (2021)

The role of PIK3CA mutations in the development of breast cancer (a literature review)
by: A. O. Pryvalova, et al.
Published: (2020-08-01)

PIK3CA mutations are specifically localized to lymphatic endothelial cells of lymphatic malformations.
by: Hannah Blesinger, et al.
Published: (2018-01-01)

Oncogenic mutations of PIK3CA and HRAS in carcinoma of cervix in South Indian women
by: Geetha kumari Konathala, et al.
Published: (2017-12-01)

Analysis of PIK3CA Mutations and Activation Pathways in Triple Negative Breast Cancer.
by: Paolo Cossu-Rocca, et al.
Published: (2015-01-01)

Mutational landscape of pan-cancer patients with PIK3CA alterations in Chinese population
by: Ding, B., et al.
Published: (2022)

PIK3CA Gene Mutations in Solid Malignancies: Association with Clinicopathological Parameters and Prognosis
by: Ali Alqahtani, et al.
Published: (2019-12-01)

AKT-Independent Signaling Downstream of Oncogenic PIK3CA Mutations in Human Cancer
by: Sandy, Peter, et al.
Published: (2015)

Germline ATM mutation and somatic PIK3CA and BCOR mutations found in an infant with aggressive orbital embryonal rhabdomyosarcoma
by: Pimkwan Jaru-ampornpan, M.D., et al.
Published: (2021-09-01)

PIK3CA exon 20 mutations are associated with poor prognosis in breast cancer patients
by: Flavia R. Mangone, et al.
Published: (2012-11-01)

Identification of PIK3CA multigene mutation patterns associated with superior prognosis in stomach cancer
by: Yu Yu, et al.
Published: (2021-04-01)

The Spectrum, Tendency and Predictive Value of PIK3CA Mutation in Chinese Colorectal Cancer Patients
by: Xinhui Fu, et al.
Published: (2021-03-01)

Development and application of highly sensitive methods for detecting of BRAF and PIK3CA gene mutations
by: Sih Wei Huang, et al.
Published: (2013)

PIK3CA and p53 Mutations by Next Generation Sequencing in Lymphoepithelioma-Like Carcinoma of the Endometrium
by: Lucie Bienfait, et al.
Published: (2018-01-01)

Blockade of VEGF-C signaling inhibits lymphatic malformations driven by oncogenic PIK3CA mutation
by: Ines Martinez-Corral, et al.
Published: (2020-06-01)

PIK3CA mutant tumors depend on oxoglutarate dehydrogenase
by: Ilic, Nina, et al.
Published: (2017)

PIK3CA activating mutations are associated with more disseminated disease at presentation and earlier recurrence in glioblastoma
by: Shota Tanaka, et al.
Published: (2019-04-01)

Mutation-Associated Phenotypic Heterogeneity in Novel and Canonical PIK3CA Helical and Kinase Domain Mutants
by: Arman Ali Ghodsinia, et al.
Published: (2020-04-01)

A Pilot Study to Non-Invasively Track PIK3CA Mutation in Head and Neck Cancer
by: Henri Schmidt, et al.
Published: (2018-11-01)

KRAS, BRAF and PIK3CA mutations and the loss of PTEN expression in Chinese patients with colorectal cancer.
by: Chen Mao, et al.
Published: (2012-01-01)